August 9, 2022 Dataset Open Access

Moldovan, Rares-Petru; Gündel, Daniel; Deuther-Conrad, Winnie; Ueberham, Lea; Kaur, Sarandeep; Otikova, Elina; Teodoro, Rodrigo; Lai, Thu Hang; Clauß, Oliver; Scheunemann, Matthias; Bormans, Guy; Kopka, Klaus; Bachmann, Michael; Brust, Peter

JSON Export

{
  "updated": "2022-08-10T12:38:36.954903+00:00", 
  "links": {
    "badge": "https://rodare.hzdr.de/badge/doi/10.14278/rodare.1381.svg", 
    "doi": "https://doi.org/10.14278/rodare.1381", 
    "conceptbadge": "https://rodare.hzdr.de/badge/doi/10.14278/rodare.1380.svg", 
    "conceptdoi": "https://doi.org/10.14278/rodare.1380", 
    "bucket": "https://rodare.hzdr.de/api/files/c0642be8-16d1-43e4-a927-6732efebb237", 
    "html": "https://rodare.hzdr.de/record/1381", 
    "latest": "https://rodare.hzdr.de/api/records/1381", 
    "latest_html": "https://rodare.hzdr.de/record/1381"
  }, 
  "conceptdoi": "10.14278/rodare.1380", 
  "id": 1381, 
  "doi": "10.14278/rodare.1381", 
  "files": [
    {
      "links": {
        "self": "https://rodare.hzdr.de/api/files/c0642be8-16d1-43e4-a927-6732efebb237/PPT_LU13_HPLC.7z"
      }, 
      "checksum": "md5:b5d90aab3caacfc3d8e5e32361b9fa5d", 
      "bucket": "c0642be8-16d1-43e4-a927-6732efebb237", 
      "size": 159811, 
      "key": "PPT_LU13_HPLC.7z", 
      "type": "7z"
    }
  ], 
  "owners": [
    471
  ], 
  "metadata": {
    "doi": "10.14278/rodare.1381", 
    "description": "<p>The cannabinoid receptor type 2 (CB2R) is an attractive target for diagnosis and therapy of neurodegenerative diseases and cancer. Recently, we reported a novel naphthyrid-2-one based positron-emission tomography (PET) radioligand for imaging of the CB2R in the brain (<strong>[<sup>18</sup>F]5</strong>). In this study we aimed at the development of a novel <sup>18</sup>F-labeled CB2R radioligand with improved binding properties and metabolic stability. Starting from the structure of <strong>5</strong>, we developed a novel series of fluorinated derivatives by modifying the substituents at the naphthyrid-2-one subunit. Compound <strong>28</strong> (<strong>LU13</strong>) was identified with the highest binding affinity and selectivity versus CB1R (CB2R<em>K</em><sub>i</sub> = 0.6 nM; CB1R<em>K</em><sub>i</sub>/CB2R<em>K</em><sub>i</sub> &gt; 1000) and was selected for radiolabeling with <sup>18</sup>F and biological characterization. The radiofluorination was performed starting from the corresponding bromo-precursor (<strong>31</strong>) bearing a fully deuterated <em>N</em>-alkyl chain to protect against defluorination. The in vitro evaluation of <strong>[<sup>18</sup>F]LU13 </strong>proved the high binding affinity of the radioligand towards rat (rCB2R<em>K</em><sub>D</sub> = 0.2 nM) and human (hCB2R<em>K</em><sub>D</sub> = 1.1 nM) CB2R. Metabolism studies in mice revealed a metabolic stability at 30 min p.i. with fractions of parent compound of &gt;80% in the brain and 90% in the spleen with only trace of defluorination products detected in plasma. PET imaging in a rat model of vector-based/related overexpression in the striatum revealed a high signal to background ratio, demonstrating the ability of <strong>[<sup>18</sup>F]LU13</strong> to reach and selectively label the hCB2R in the brain. Thus, <strong>[<sup>18</sup>F]LU13 </strong>is a novel and highly promising PET radioligand for the imaging of up regulated CB2R expression under pathological conditions in the brain.</p>", 
    "doc_id": "1", 
    "related_identifiers": [
      {
        "relation": "isIdenticalTo", 
        "scheme": "url", 
        "identifier": "https://www.hzdr.de/publications/Publ-34030"
      }, 
      {
        "relation": "isReferencedBy", 
        "scheme": "url", 
        "identifier": "https://www.hzdr.de/publications/Publ-33987"
      }, 
      {
        "relation": "isVersionOf", 
        "scheme": "doi", 
        "identifier": "10.14278/rodare.1380"
      }
    ], 
    "access_right_category": "success", 
    "pub_id": "34030", 
    "access_right": "open", 
    "relations": {
      "version": [
        {
          "index": 0, 
          "last_child": {
            "pid_value": "1381", 
            "pid_type": "recid"
          }, 
          "is_last": true, 
          "count": 1, 
          "parent": {
            "pid_value": "1380", 
            "pid_type": "recid"
          }
        }
      ]
    }, 
    "resource_type": {
      "type": "dataset", 
      "title": "Dataset"
    }, 
    "license": {
      "id": "CC-BY-4.0"
    }, 
    "title": "Data Publication: Structure-Based Design, Optimization and Development of [18F]LU13, a novel radioligand for CB2R Imaging in the Brain with PET", 
    "creators": [
      {
        "affiliation": "HZDR", 
        "orcid": "0000-0003-3119-7945", 
        "name": "Moldovan, Rares-Petru"
      }, 
      {
        "affiliation": "HZDR", 
        "orcid": "0000-0001-9743-2325", 
        "name": "G\u00fcndel, Daniel"
      }, 
      {
        "affiliation": "HZDR", 
        "orcid": "0000-0003-3168-3062", 
        "name": "Deuther-Conrad, Winnie"
      }, 
      {
        "name": "Ueberham, Lea"
      }, 
      {
        "affiliation": "HZDR", 
        "name": "Kaur, Sarandeep"
      }, 
      {
        "name": "Otikova, Elina"
      }, 
      {
        "affiliation": "HZDR", 
        "orcid": "0000-0002-1425-0567", 
        "name": "Teodoro, Rodrigo"
      }, 
      {
        "affiliation": "HZDR", 
        "orcid": "0000-0001-8157-8979", 
        "name": "Lai, Thu Hang"
      }, 
      {
        "affiliation": "HZDR", 
        "orcid": "0000-0001-5067-4845", 
        "name": "Clau\u00df, Oliver"
      }, 
      {
        "affiliation": "HZDR", 
        "name": "Scheunemann, Matthias"
      }, 
      {
        "name": "Bormans, Guy"
      }, 
      {
        "affiliation": "HZDR", 
        "orcid": "0000-0003-4846-1271", 
        "name": "Kopka, Klaus"
      }, 
      {
        "affiliation": "HZDR", 
        "orcid": "0000-0002-8029-5755", 
        "name": "Bachmann, Michael"
      }, 
      {
        "affiliation": "HZDR", 
        "orcid": "0000-0001-5555-7058", 
        "name": "Brust, Peter"
      }
    ], 
    "communities": [
      {
        "id": "health"
      }, 
      {
        "id": "rodare"
      }
    ], 
    "publication_date": "2022-08-09", 
    "keywords": [
      "cannabinoid receptor type 2", 
      "naphthyrid-2-one", 
      "binding affinity"
    ]
  }, 
  "revision": 6, 
  "conceptrecid": "1380", 
  "created": "2022-08-09T11:33:20.476163+00:00", 
  "stats": {
    "volume": 51778764.0, 
    "unique_downloads": 78.0, 
    "version_unique_downloads": 78.0, 
    "unique_views": 706.0, 
    "downloads": 324.0, 
    "version_unique_views": 706.0, 
    "version_views": 1234.0, 
    "version_downloads": 324.0, 
    "version_volume": 51778764.0, 
    "views": 1234.0
  }
}